• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Cognixion inks strategic BCI partnership with Pupil Labs

Cognixion inks strategic BCI partnership with Pupil Labs

June 4, 2025 By Sean Whooley

Cognixion Axon R
The Axon-R system in use. [Image courtesy of Cognixion]

Cognixion announced today that it entered into a strategic partnership with Pupil Labs GmbH to integrate eye-tracking software with a neural interface.

The two companies agreed to integrate technologies to deliver an interface that measures both visual attention and neural signals. They plan to connect Pupil Labs’ sophisticated eye-tracking software with Cognixion’s Axon-R SDK. This could enable seamless data collection and analysis across platforms.

Cognixion developed Axon-R as a non-invasive, wearable neural interface device. It uses advanced brain-computer interface (BCI) electroencephalogram (EEG) capabilities. The device enables precise measurement and modulation of brain activity through visual stimuli, biofeedback and neurofeedback.

The company designed the investigational Axon-R with personalized, generative AI communication software. It could restore the ability to communicate for individuals who have lost the capability to do so through conventional means like speech, facial movement or eye glances.

Cognixion says high-precision eye tracking and advanced BCI EEG capabilities can give clinical researchers powerful new tools for neuroscience, human-computer interaction and assistive technology research. The companies say their combined technology can provide a higher level of data confidence. It also adapts to the unique needs of patients where disease progression may impact eye gaze ability, like in ALS.

According to a news release, the partnership addresses a significant need for unified tools that can simultaneously track visual attention and neural activity with research-grade precision. 

The companies plan to enable researchers to rapidly prototype and deploy studies measuring eye movement and brain activity simultaneously. They expect researchers to leverage research-grade sensors for both modalities and access synchronized data streams. Then, they can develop applications that respond to both visual attention and neural signals.

Cognixion and Pupil Labs expect initial releases of their integrated offering within six months. The company recently entered into a similar research-based collaboration with Blackrock Neurotech, too.

“By combining Cognixion’s neural interface expertise with Pupil Labs’ industry-leading eye tracking technology, we’re filling a critical role in sensor architecture that isn’t available with any current brain-computer interface technologies,” said Andreas Forsland, CEO of Cognixion. “This partnership enables a new generation of studies that can correlate visual attention with neural activity in real-time, potentially transforming our understanding of human cognition and interaction.”

Filed Under: Artificial Intelligence (AI), Brain-Computer Interface (BCI), Business/Financial News, Health Technology, Neurological, Research & Development, Software / IT, Vision Tagged With: Cognixion

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy